MAY 14, 2021 4:26 PM PDT

How COVID-19 Patients Lose Their Sense of Smell

WRITTEN BY: Carmen Leitch

The loss of the sense of smell is a well-known symptom of COVID-19 and has been common even in people that did not have many other symptoms. Researchers have now learned more about how the SARS-CoV-2 virus infects cells in the nose and leads to a sudden loss of smell or anosmia. The work has suggested that the virus can invade sensory neurons, causing persistent inflammation in the olfactory system. In some patients who lose their sense of smell for a long time, viral particles seem to persist in the olfactory epithelium and neurons.

Colorized scanning electron micrograph of CCL-81 Cells infected with SARS-CoV-2 virus particles (green), isolated from a patient sample. The tentacle-like protrusions from the cells are filapodia, which extend from infected cells, attach to neighboring cells, and promote viral infection as a transport system for virus particles. Image captured at the NIAID Integrated Research Facility (IRF) in Fort Detrick, Maryland. Credit: NIAID

There was also an unexpected finding of this study. It seems that regular qRT-PCR tests that use nasal swabs samples to detect the virus can test negative, even when the virus is still hanging out in the back of the nasal cavity in the olfactory epithelium. However, the virus may be detectable in these cases with nasal brushes, which cause more discomfort but gather more cells. The findings have been reported in Science Translational Medicine.

The researchers have laid out a series of steps in SARS-CoV-2 infections that leads to anosmia. After the infection begins, cellular antenna called cilia are lost from neurons. Normally, these cilia detect odor molecules. The virus is detectable in neurons at this point, and olfactory epithelial cells begin to die off through apoptosis, a programmed cell death pathway. The epithelium gets reorganized by the virus, and the virus spreads to the olfactory bulb, where smell information is first relayed to the brain. Viral RNA and inflammation can then be detected in several parts of the brain. The sensory organ in the rear of the nasal cavity also begins to break down.

 "We observed that SARS-CoV-2 infects not only the sensory neurons, but also the olfactory nerve and the olfactory nerve centers in the brain," said study co-author Pierre-Marie Lledo, head of the Perception and Memory Unit at the Institut Pasteur/CNRS.

"Another key finding from this study emerged from an observation of animal models, which revealed that once the virus enters the olfactory bulb, it spreads to other nerve structures, where it induces a major inflammatory response," noted study co-author Hervé Bourhy, head of the Lyssavirus Epidemiology and Neuropathology Unit at the Institut Pasteur.

The olfactory neurons have been proposed as a route the virus can take to the brain, and may help explain why some COVID-19 patients have psychological symptoms.

"According to our results, loss of smell in COVID-19 may persist for several months in some patients and this persistence of clinical signs may be attributed to the persistence of the virus and inflammation in the olfactory mucosa," added study co-author Marc Lecuit, head of the Biology of Infection Unit at the Institut Pasteur, Inserm, Université de Paris, AP-HP.

Sources: AAAS/Eurekalert! via Institut Pasteur, Science Translational Medicine

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
JAN 06, 2021
Clinical & Molecular DX
COVID Patients Can't Stop and Smell the Roses
JAN 06, 2021
COVID Patients Can't Stop and Smell the Roses
A study of over 2,500 European patients has revealed that 85.9 percent of those with mild COVID-19 symptoms lost their s ...
JAN 23, 2021
Cancer
Quantifying delays in radiotherapy during the pandemic
JAN 23, 2021
Quantifying delays in radiotherapy during the pandemic
Researchers from the University of Leeds, Public Health England, and the Royal College of Radiologists have investigated ...
FEB 25, 2021
Clinical & Molecular DX
A Better Way to Triage COVID Patients
FEB 25, 2021
A Better Way to Triage COVID Patients
Australian researchers have developed a COVID-19 triaging tool that serves as a crystal ball for healthcare workers. Onc ...
APR 02, 2021
Drug Discovery & Development
Anti-Parasitic Medication Could Be Therapy for COVID19
APR 02, 2021
Anti-Parasitic Medication Could Be Therapy for COVID19
What are tropical and neglected diseases? Chronic infections that plague developing nations with often little financial ...
APR 22, 2021
Drug Discovery & Development
mRNA Covid Vaccines May Protect Against New Strains and Common Cold
APR 22, 2021
mRNA Covid Vaccines May Protect Against New Strains and Common Cold
Researchers from Johns Hopkins have found that the mRNA Covid vaccines developed by Pfizer and Moderna not only work wit ...
MAY 19, 2021
Technology
Nanobodies May Help Prevent Overactivation of the Immune System in COVID-19 Infections
MAY 19, 2021
Nanobodies May Help Prevent Overactivation of the Immune System in COVID-19 Infections
Attempts to understand the SARS-CoV-2 virus have focused on a key mechanism of action: the use of a “spike pr ...
Loading Comments...